Loading TGTX charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading TGTX comparable companies…
| TGTXTG Therapeutics, Inc.(opens in a new tab) | $9.63B | $0.80B | +76.1% | 82.4% | 17.1% | 12.04× | 22.3× |
|---|---|---|---|---|---|---|---|
| COLLCollegium Pharmaceutical, Inc.(opens in a new tab) | $0.77B | $0.81B | +14.3% | 60.0% | 19.5% | 0.96× | 19.2× |
| AXSMAxsome Therapeutics, Inc.(opens in a new tab) | $7.49B | $0.78B | +56.9% | 93.2% | −24.0% | 9.65× | — |
| ASNDAscendis Pharma A/S(opens in a new tab) | $15.38B | $0.82B | +110.1% | 86.9% | −17.7% | — | — |
| EBSEmergent BioSolutions Inc.(opens in a new tab) | $0.35B | $0.77B | −9.6% | 55.9% | −8.6% | 0.46× | — |
| Medianpeers, excl. TGTX | $4.13B | $0.79B | +35.6% | 73.5% | −13.1% | 0.96× | 19.2× |